Cost–utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma

por Muszbek, Noemi, Remak, Edit, Xin, Qian, McNamara, Linda, Jones, Trefor
Publicado 2023

Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology

por Inotai, András, Pékli, Márta, Jóna, Gabriella, Nagy, Orsolya, Remák, Edit, Kaló, Zoltán
Publicado 2012

Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom

por Abogunrin, Seye, Hortobagyi, Linda, Remak, Edit, Dinet, Jerome, Gabriel, Sylvie, Bakheit, Abdel Magid O
Publicado 2015

A cost-consequence analysis of parecoxib and opioids vs opioids alone for postoperative pain: Chinese perspective

por Barra, Magdolna, Remák, Edit, Liu, Dong Dong, Xie, Li, Abraham, Lucy, Sadosky, Alesia B
Publicado 2019

Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System

por Torres, Antoni, Soriano, Alex, Rivolo, Simone, Remak, Edit, Peral, Carmen, Kantecki, Michal, Ansari, Wajeeha, Charbonneau, Claudie, Hammond, Jennifer, Grau, Santiago, Wilcox, Mark
Publicado 2022